Cargando…

Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study

The effective early prediction of clinical outcomes of Parkinson's disease (PD) is of great significance in the implementation of appropriate interventions. We aimed to propose a method based on the use of baseline resting‐state functional characteristics (i.e., fractional amplitude of low‐freq...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yanbing, Zhang, Lingyu, Ou, Ruwei, Wei, Qianqian, Gu, Xiaojing, Liu, Kuncheng, Lin, Junyu, Yang, Tianmi, Xiao, Yi, Gong, Qiyong, Shang, Huifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875914/
https://www.ncbi.nlm.nih.gov/pubmed/36250699
http://dx.doi.org/10.1002/hbm.26110
_version_ 1784878051900784640
author Hou, Yanbing
Zhang, Lingyu
Ou, Ruwei
Wei, Qianqian
Gu, Xiaojing
Liu, Kuncheng
Lin, Junyu
Yang, Tianmi
Xiao, Yi
Gong, Qiyong
Shang, Huifang
author_facet Hou, Yanbing
Zhang, Lingyu
Ou, Ruwei
Wei, Qianqian
Gu, Xiaojing
Liu, Kuncheng
Lin, Junyu
Yang, Tianmi
Xiao, Yi
Gong, Qiyong
Shang, Huifang
author_sort Hou, Yanbing
collection PubMed
description The effective early prediction of clinical outcomes of Parkinson's disease (PD) is of great significance in the implementation of appropriate interventions. We aimed to propose a method based on the use of baseline resting‐state functional characteristics (i.e., fractional amplitude of low‐frequency fluctuations, fALFF) to predict motor progression in PD patients. Resting‐state functional magnetic resonance imaging was performed on 48 newly‐diagnosed drug‐naïve PD patients and 27 age‐ and sex‐ matched healthy controls (HCs). Two PD subgroups were defined with different annual increase of Unified PD Rating Scale Part III motor scores. Least absolute shrinkage and selection operator regression analysis was performed to explore the baseline region‐functional indicators for PD discrimination as well as the predictors for future motor deficits. Two significant models composed of baseline fALFF values from cerebral subregions were proposed. The classification model that distinguished PD patients from HCs (area under the curve [AUC] = 0.897) showed the most significant imaging characteristics in the putamen and precentral gyrus. The other prediction model that evaluated the degree of future deterioration of motor symptoms in PD patients (AUC = 0.916) showed the most significant imaging characteristics in the superior occipital gyrus and caudate nucleus. Furthermore, the increased regional function in bilateral caudate nuclei was correlated with the lower annual increase in motor deficits in all PD patients. The caudate nucleus might be the core region responsible for future motor deficits in newly‐diagnosed PD patients, which may aid the development of disease progression preventive strategies in clinical practice.
format Online
Article
Text
id pubmed-9875914
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-98759142023-01-25 Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study Hou, Yanbing Zhang, Lingyu Ou, Ruwei Wei, Qianqian Gu, Xiaojing Liu, Kuncheng Lin, Junyu Yang, Tianmi Xiao, Yi Gong, Qiyong Shang, Huifang Hum Brain Mapp Research Articles The effective early prediction of clinical outcomes of Parkinson's disease (PD) is of great significance in the implementation of appropriate interventions. We aimed to propose a method based on the use of baseline resting‐state functional characteristics (i.e., fractional amplitude of low‐frequency fluctuations, fALFF) to predict motor progression in PD patients. Resting‐state functional magnetic resonance imaging was performed on 48 newly‐diagnosed drug‐naïve PD patients and 27 age‐ and sex‐ matched healthy controls (HCs). Two PD subgroups were defined with different annual increase of Unified PD Rating Scale Part III motor scores. Least absolute shrinkage and selection operator regression analysis was performed to explore the baseline region‐functional indicators for PD discrimination as well as the predictors for future motor deficits. Two significant models composed of baseline fALFF values from cerebral subregions were proposed. The classification model that distinguished PD patients from HCs (area under the curve [AUC] = 0.897) showed the most significant imaging characteristics in the putamen and precentral gyrus. The other prediction model that evaluated the degree of future deterioration of motor symptoms in PD patients (AUC = 0.916) showed the most significant imaging characteristics in the superior occipital gyrus and caudate nucleus. Furthermore, the increased regional function in bilateral caudate nuclei was correlated with the lower annual increase in motor deficits in all PD patients. The caudate nucleus might be the core region responsible for future motor deficits in newly‐diagnosed PD patients, which may aid the development of disease progression preventive strategies in clinical practice. John Wiley & Sons, Inc. 2022-10-17 /pmc/articles/PMC9875914/ /pubmed/36250699 http://dx.doi.org/10.1002/hbm.26110 Text en © 2022 The Authors. Human Brain Mapping published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Hou, Yanbing
Zhang, Lingyu
Ou, Ruwei
Wei, Qianqian
Gu, Xiaojing
Liu, Kuncheng
Lin, Junyu
Yang, Tianmi
Xiao, Yi
Gong, Qiyong
Shang, Huifang
Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study
title Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study
title_full Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study
title_fullStr Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study
title_full_unstemmed Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study
title_short Motor progression marker for newly diagnosed drug‐naïve patients with Parkinson's disease: A resting‐state functional MRI study
title_sort motor progression marker for newly diagnosed drug‐naïve patients with parkinson's disease: a resting‐state functional mri study
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875914/
https://www.ncbi.nlm.nih.gov/pubmed/36250699
http://dx.doi.org/10.1002/hbm.26110
work_keys_str_mv AT houyanbing motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT zhanglingyu motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT ouruwei motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT weiqianqian motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT guxiaojing motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT liukuncheng motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT linjunyu motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT yangtianmi motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT xiaoyi motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT gongqiyong motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy
AT shanghuifang motorprogressionmarkerfornewlydiagnoseddrugnaivepatientswithparkinsonsdiseasearestingstatefunctionalmristudy